|
1 / 1
|
DeCS
|
|
 |
|
Descriptor English:
|
|
Cabergoline
|
|
Descriptor Spanish:
|
|
Cabergolina
|
|
Descriptor Portuguese:
|
|
Cabergolina
|
|
Synonyms English:
|
|
1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
Cabaser
Cabaseril
Cabergoline Diphosphate
Dostinex
FCE 21336
FCE-21336
Galastop
|
|
Tree Number:
|
|
D03.132.327.287.131
D03.633.400.439.197
|
|
Definition English:
|
|
An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE. |
|
Pharmacological Action:
|
|
Antiparkinson Agents
Dopamine Agonists
|
|
History Note English:
|
|
2019 (1985)
|
|
Allowable Qualifiers English:
|
|
|
|
Record Number:
|
|
57653
|
|
Unique Identifier:
|
|
D000077465
|
Occurrence in VHL:
|
|
|
Similar:
|
|
DeCS
|